These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 16580256

  • 1. Peroxisome proliferator-activated receptors and acute lung injury.
    Cuzzocrea S.
    Curr Opin Pharmacol; 2006 Jun; 6(3):263-70. PubMed ID: 16580256
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury.
    Cuzzocrea S.
    Vascul Pharmacol; 2004 Jul; 41(6):187-95. PubMed ID: 15653094
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG, Hele DJ, Birrell MA.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):101-9. PubMed ID: 16458290
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 08; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 5. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes.
    Ibabe A, Herrero A, Cajaraville MP.
    Toxicol In Vitro; 2005 Sep 08; 19(6):725-35. PubMed ID: 15964169
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
    Abdelrahman M, Sivarajah A, Thiemermann C.
    Cardiovasc Res; 2005 Mar 01; 65(4):772-81. PubMed ID: 15721857
    [Abstract] [Full Text] [Related]

  • 7. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T, Esposito E, Mazzon E, Di Paola R, Muià C, Meli R, Bramanti P, Cuzzocrea S.
    Shock; 2008 Aug 01; 30(2):142-52. PubMed ID: 18628687
    [Abstract] [Full Text] [Related]

  • 8. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ.
    Shock; 2006 Sep 01; 26(3):262-70. PubMed ID: 16912651
    [Abstract] [Full Text] [Related]

  • 9. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
    Becker J, Delayre-Orthez C, Frossard N, Pons F.
    Fundam Clin Pharmacol; 2006 Oct 01; 20(5):429-47. PubMed ID: 16968414
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
    Liu J, Lu H, Huang R, Lin D, Wu X, Lin Q, Wu X, Zheng J, Pan X, Peng J, Song Y, Zhang M, Hou M, Chen F.
    Cancer Chemother Pharmacol; 2005 Oct 01; 56(4):400-8. PubMed ID: 15838654
    [Abstract] [Full Text] [Related]

  • 11. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Fulia F, Cuzzocrea E, Di Rosa M, Caputi AP, Thiemermann C.
    Crit Care Med; 2004 Feb 01; 32(2):457-66. PubMed ID: 14758164
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep 01; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 13. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S.
    Neuroscience; 2005 Sep 01; 130(2):325-37. PubMed ID: 15664689
    [Abstract] [Full Text] [Related]

  • 14. The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation.
    Cuzzocrea S, Mazzon E, Di Paola R, Peli A, Bonato A, Britti D, Genovese T, Muià C, Crisafulli C, Caputi AP.
    J Leukoc Biol; 2006 May 01; 79(5):999-1010. PubMed ID: 16501055
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
    Bernardo A, Bianchi D, Magnaghi V, Minghetti L.
    J Neuropathol Exp Neurol; 2009 Jul 01; 68(7):797-808. PubMed ID: 19535992
    [Abstract] [Full Text] [Related]

  • 16. Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure.
    Thiemermann C.
    Br J Pharmacol; 2004 Jul 01; 142(6):1049-51. PubMed ID: 15303252
    [Abstract] [Full Text] [Related]

  • 17. Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetes.
    Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ.
    Am J Ther; 2007 Jul 01; 14(1):49-62. PubMed ID: 17303976
    [Abstract] [Full Text] [Related]

  • 18. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
    Libby P, Plutzky J.
    Am J Cardiol; 2007 Feb 19; 99(4A):27B-40B. PubMed ID: 17307056
    [Abstract] [Full Text] [Related]

  • 19. Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma.
    Genovese T, Mazzon E, Di Paola R, Cannavò G, Muià C, Bramanti P, Cuzzocrea S.
    Exp Neurol; 2005 Jul 19; 194(1):267-78. PubMed ID: 15899263
    [Abstract] [Full Text] [Related]

  • 20. PPAR-gamma: therapeutic target for ischemic stroke.
    Culman J, Zhao Y, Gohlke P, Herdegen T.
    Trends Pharmacol Sci; 2007 May 19; 28(5):244-9. PubMed ID: 17416424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.